] Shares ARATANA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 6th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000005Exclusive Ip License Agreement • June 6th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
This EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000005 (this “Agreement”) is entered into as of December 27, 2010 (the “Effective Date”) by and between Aratana Therapeutics Inc., a Delaware corporation having a place of business is 1901 Olathe Boulevard, Kansas City, KS 66103 (“Licensee”) and RaQualia Pharma Inc., a Japanese corporation having a place of business at 5-2 Taketoyo, Aichi 470-2341, Japan (“Licensor”).
API DEVELOPMENT AGREEMENTApi Development Agreement • June 6th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
This API DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of July 12, 2012 (the “Effective Date”) by and between Aratana Therapeutics Inc., a Delaware corporation (“Aratana”) and RaQualia Pharma Inc., a Japanese corporation (“RaQualia”). Aratana and RaQualia are referred to herein individually as a “Party” and collectively as the “Parties”.
EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000007Exclusive Ip License Agreement • June 6th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
This EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000007 (this “Agreement”) is entered into as of December 27 2010 (the “Effective Date”) by and between. Aratana Therapeutics Inc., a Delaware corporation having a place of business is 1901 Olathe Boulevard, Kansas City, KS 66103 (“Licensee”) and RaQualia Pharma Inc., a Japanese corporation having a place of business at 5-2 Taketoyo, Aichi 470-2341, Japan (“Licensor”).
